Innovating to improve health worldwide

We are the voice of the innovative pharmaceutical industry, collaborating for global health progress to improve lives everywhere.

Areas of work About us

Latest news

Statement 5 June 2023

G20 3rd Health Working Group Meeting: Health Emergencies Prevention, Preparedness, and Response (HEPPR)

On 4 June, IFPMA delivered a statement on Priority I “Health Emergencies Prevention, Preparedness, and Response” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Statement 5 June 2023

G20 3rd Health Working Group Meeting: Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)

On 4 June, IFPMA delivered a statement on Priority II “Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Expert insights 5 June 2023

An ambitious World Health Assembly aims to get global health back on track

The 76th World Health Assembly (WHA) was the first since the World Health Organization declared that COVID-19 was no longer a Public Health Emergency of International Concern. My WHA kicked off with IFPMA colleagues at the WHO Walk the Talk, which was a healthy start to a busy week ahead. The agenda saw a focus...

Read more
Statement 5 June 2023

G20 side event on Global Vaccine Research Collaborative

On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Statement
G20 3rd Health Working Group Meeting: Health Emergencies Prevention, Preparedness, and Response (HEPPR)
Statement
G20 3rd Health Working Group Meeting: Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)
Expert insights
An ambitious World Health Assembly aims to get global health back on track
Statement
G20 side event on Global Vaccine Research Collaborative

Initiatives

See all

#AlwaysInnovating: The pharmaceutical innovation journey

#AlwaysInnovating lifts the curtain on this innovation journey, revealing what's needed to turn an idea into a medicine or vaccine that brings hope to people everywhere.

Learn More

Global Health Progress

Explore how the innovative pharmaceutical industry is collaborating across global health actors to support the Sustainable Development Goals in low- and middle-income countries.

Learn more

Covid-19 Hub

Discover the innovative pharmaceutical industry’s response to the COVID-19 pandemic to inform how we can better prepare for the next public health crisis.

Learn more

50 Years of Progress

Engage with the personal stories of individuals whose lives have been transformed over 50 years of building a better world through health innovations, overcoming challenges, making scientific advances, and partnering for progress.

Learn more

Collaborating for global health progress

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the innovative pharmaceutical industry at the international level and in official relations with the United Nations.

About us

Areas of work

See all

Fostering a thriving health innovation ecosystem

Advancing sustainable health systems

Improving health security and pandemic preparedness

Strengthening regulatory systems

Upholding ethics and business integrity

Supporting Africa’s health ecosystem  

Our members

Representing over 90 of the most forward-looking companies and associations in the world.

See all
Top